FCCC LOGO Faculty Publications
Narra K , Borghaei H , Al-Saleem T , Hoglund M , Smith MR
Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature
Leukemia Research. 2006 Jan;30(1) :109-14
PMID: 16043218   
Back to previous list
Abstract
Pure red cell aplasia (PRCA) is an unusual cause of anemia in patients with chronic lymphoproliferative disorders. Here, we present two cases of PRCA, one associated with chronic lymphocytic leukemia (CLL) and the other with splenic marginal zone lymphoma, in which the PRCA responded dramatically to treatment with rituximab. We then review the literature on PRCA in lymphoma and response to rituximab. PRCA associated with CLL or lymphoma may be another indication for rituximab therapy.
Notes
England Case Reports Journal Article